PRL-8-53 1000 mg in a single dose human study of improved short-term memory by more than 200% safe in animal studies it had significantly active nootropic properties.
PRL-8-53 is a synthetic research chemical that has intrigued the nootropic community for decades.
There has been only one human study on PRL-8-53 in 40 years since it was discovered.
The data revealed that a single dose of PRL-8-53 improved short-term memory by more than 200%.
A derivative of benzoic acid and phenylethylamine, it was researched in 1972 by the patent holder Dr. Nikolaus Hansl.
Research into PRL-8-53 has not been ongoing, but the compound is available and has a cult following of nootropic aficionados.
Animal studies showed that it was both safe and significantly effective nootropic agent.
Notable effects of April-8-53 was a boosting in enhanced learning and subsequent avoidance learning in rodents, with no side effects.
In 1978 a short 24-hour human study of 47 volunteers using 5mg via oral dosing was conducted.
Prl-8-53 enhanced knowledge and showed a single dose showed to improve memory 200%.
No Side effects had occurred or were reported by participants.